Portage Biotech Inc.
PRTG
$5.53
-$0.50-8.29%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -67.28M | -71.08M | -75.34M | -144.90M | -113.01M |
| Total Depreciation and Amortization | 43.00K | 51.00K | 54.00K | 41.00K | 27.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 57.11M | 57.20M | 60.01M | 129.11M | 96.98M |
| Change in Net Operating Assets | 327.00K | 1.30M | 982.00K | -111.00K | 876.00K |
| Cash from Operations | -9.80M | -12.53M | -14.30M | -15.86M | -15.13M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.81M | 2.81M | 2.81M | 0.00 | 0.00 |
| Cash from Investing | 2.81M | 2.81M | 2.81M | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -42.00K | -42.00K | -40.00K | -28.00K | -17.00K |
| Issuance of Common Stock | 5.34M | 5.39M | 6.02M | 8.21M | 3.66M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.00K | 7.00K | -12.00K | -86.00K | -110.00K |
| Cash from Financing | 5.31M | 5.35M | 5.97M | 8.09M | 3.54M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.68M | -4.36M | -5.52M | -7.76M | -11.59M |
